| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yue Wu, Zhongting Zhao, Naidi Yang, Chenqi Xin, Zheng Li, Jiajia Xu, Bo Ma, Kah-Leong Lim, Lin Li, Qiong Wu, Changmin Yu, Chengwu Zhan. Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson's Disease Models by Alleviating Oxidative Stress. Antioxidants (Basel, Switzerland). vol 12. issue 1. 2023-01-21. PMID:36671015. |
parkinson's disease (pd) is the second most common neurodegenerative disease characterized by progressive loss of dopaminergic neurons in the substantia nigra of the midbrain. |
2023-01-21 |
2023-08-14 |
Not clear |
| Minyoung Oh, Juhyeon Nam, Areum Baek, Ji-Hye Seo, Jung-Il Chae, Seo-Young Lee, Sun-Ku Chung, Byoung Chul Park, Sung Goo Park, Janghwan Kim, Young-Joo Jeo. Neuroprotective Effects of Licochalcone D in Oxidative-Stress-Induced Primitive Neural Stem Cells from Parkinson's Disease Patient-Derived iPSCs. Biomedicines. vol 11. issue 1. 2023-01-21. PMID:36672736. |
parkinson's disease (pd) is one of the most common neurodegenerative diseases caused by the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2023-01-21 |
2023-08-14 |
Not clear |
| Nicola Paccione, Mahdieh Rahmani, Emilia Barcia, Sofía Negr. Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems. Pharmaceutics. vol 15. issue 1. 2023-01-21. PMID:36678642. |
parkinson's disease (pd) is a devastating neurodegenerative disease characterized by progressive destruction of dopaminergic tissue in the central nervous system (cns). |
2023-01-21 |
2023-08-14 |
Not clear |
| Meimei Xing, Guoyun Li, Yang Liu, Luyao Yang, Youjiao Zhang, Yuruo Zhang, Jianhua Ding, Ming Lu, Guangli Yu, Gang H. Fucoidan from Fucus vesiculosus prevents the loss of dopaminergic neurons by alleviating mitochondrial dysfunction through targeting ATP5F1a. Carbohydrate polymers. vol 303. 2023-01-19. PMID:36657849. |
parkinson's disease is a neurodegenerative disease that is characterized by the loss of dopaminergic neurons. |
2023-01-19 |
2023-08-14 |
mouse |
| Tian-Kuo Lee, K Ashok Kumar, Chih-Yang Huang, Po-Hsiang Liao, Tsung-Jung Ho, Wei-Wen Kuo, Shih-Chieh Liao, Dennis Jine-Yuan Hsieh, Ping-Ling Chiu, Yung-Ming Chang, Da-Tong J. Garcinol protects SH-SY5Y cells against MPP+-induced cell death by activating DJ-1/SIRT1 and PGC-1α mediated antioxidant pathway in sequential stimulation of p-AMPK mediated autophagy. Environmental toxicology. 2023-01-11. PMID:36629037. |
parkinson's disease (pd), a chronic and progressive neurodegenerative disease, can reduce the population of dopaminergic neurons in the substantia nigra. |
2023-01-11 |
2023-08-14 |
human |
| Bruk Getachew, Antonei B Csoka, Robert L Copeland, Kebreten F Manaye, Yousef Tizab. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease. Neurotoxicity research. 2022-12-30. PMID:36585544. |
parkinson's disease (pd) is a progressive neurodegenerative disease associated with loss of dopaminergic neurons in the substantia nigra pars compacta. |
2022-12-30 |
2023-08-14 |
human |
| Xing-Jie Xu, Tao Pan, Hui-Jie Fan, Xu Wang, Jie-Zhong Yu, Hai-Fei Zhang, Bao-Guo Xiao, Zhen-Yu Li, Bo Zhang, Cun-Gen Ma, Zhi Cha. Neuroprotective effect of hyperoside in MPP Metabolic brain disease. 2022-12-28. PMID:36576692. |
neuroprotective effect of hyperoside in mpp parkinson's disease (pd) is a neurodegenerative disease characterized by the pathological loss of nigrostriatal dopaminergic neurons, which causes an insufficient release of dopamine (da) and then induces motor and nonmotor symptoms. |
2022-12-28 |
2023-08-14 |
Not clear |
| Giselle Prunell, Silvia Olivera-Brav. A Focus on Astrocyte Contribution to Parkinson's Disease Etiology. Biomolecules. vol 12. issue 12. 2022-12-23. PMID:36551173. |
parkinson's disease (pd) is an incurable neurodegenerative disease of high prevalence, characterized by the prominent death of dopaminergic neurons in the substantia nigra pars compacta, which produces dopamine deficiency, leading to classic motor symptoms. |
2022-12-23 |
2023-08-14 |
Not clear |
| Jace Jones-Taba. Targeting G protein-coupled receptors in the treatment of Parkinson's disease. Journal of molecular biology. 2022-12-23. PMID:36563742. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized in part by the deterioration of dopaminergic neurons which leads to motor impairment. |
2022-12-23 |
2023-08-14 |
Not clear |
| Xin-Yi Chen, Cui Liu, Yan Xue, Lei Che. Changed firing activity of nigra dopaminergic neurons in Parkinson's disease. Neurochemistry international. 2022-12-23. PMID:36563966. |
parkinson's disease is the second most common neurodegenerative disease which is characterized by selective degeneration of dopaminergic neurons in the substantia nigra pars compacta. |
2022-12-23 |
2023-08-14 |
Not clear |
| Changcheng Lu, Shuhui Qu, Zhangfeng Zhong, Hua Luo, Si San Lei, Hai-Jing Zhong, Huanxing Su, Yitao Wang, Cheong-Meng Chon. The effects of bioactive components from the rhizome of Frontiers in pharmacology. vol 13. 2022-12-19. PMID:36532787. |
the effects of bioactive components from the rhizome of parkinson's disease (pd) is an age-related chronic neurodegenerative disease caused by the death and degeneration of dopaminergic neurons in the substantia nigra of the midbrain. |
2022-12-19 |
2023-08-14 |
Not clear |
| Robert Brendza, Xiaoying Gao, Kimberly L Stark, Han Lin, Seung-Hye Lee, Changyun Hu, Hao Cai, Danielle DiCara, Yi-Chun Hsiao, Hai Ngu, Oded Foreman, Miriam Baca, Monika Dohse, Jean-Phillipe Fortin, Racquel Corpuz, Dhaya Seshasayee, Amy Easton, Gai Ayalon, Isidro Hötzel, Ben Chi. Anti-α-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's disease. Neurobiology of disease. 2022-12-19. PMID:36535551. |
parkinson's disease (pd), a neurodegenerative disease affecting dopaminergic (da) neurons, is characterized by decline of motor function and cognition. |
2022-12-19 |
2023-08-14 |
mouse |
| Hong-Yang Sun, Jin Wu, Rui Wang, Shun Zhang, Hao Xu, Еlena Kaznacheyeva, Xiao-Jun Lu, Hai-Gang Ren, Guang-Hui Wan. Pazopanib alleviates neuroinflammation and protects dopaminergic neurons in LPS-stimulated mouse model by inhibiting MEK4-JNK-AP-1 pathway. Acta pharmacologica Sinica. 2022-12-19. PMID:36536076. |
parkinson's disease (pd) is a progressive neurodegenerative disease characterized by the loss of dopaminergic (da) neurons and the accumulation of lewy bodies (lb) in the substantia nigra (sn). |
2022-12-19 |
2023-08-14 |
mouse |
| Erlânia Alves de Siqueira, Emanuel Paula Magalhães, Ramon Róseo Paula Pessoa Bezerra de Menezes, Tiago Lima Sampaio, Danya Bandeira Lima, Conceição da Silva Martins, Kelly Rose Tavares Neves, Gerly Anne de Castro Brito, Alice Maria Costa Martins, Glauce Socorro de Barros Vian. Vitamin D3 actions on astrocyte cells: a target for therapeutic strategy in Parkinson's disease? Neuroscience letters. 2022-12-05. PMID:36470505. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the loss of dopaminergic cells in the substantia nigra pars compacta. |
2022-12-05 |
2023-08-14 |
Not clear |
| Ahsas Goyal, Anant Agrawal, Aanchal Verma, Nandini Dube. The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease. Experimental and molecular pathology. 2022-11-27. PMID:36436571. |
parkinson's disease is a common progressive and multifactorial neurodegenerative disease, characterized by the loss of midbrain dopaminergic neurons. |
2022-11-27 |
2023-08-14 |
Not clear |
| Xóchitl Flores-Ponce, Adolfo López-Ornelas, Itzel Escobedo-Avila, Mayela Rodríguez-Violante, David Dávila-Ortiz de Montellano, Amín Cervantes-Arriaga, Nancy Monroy-Jaramillo, Iván Velasc. Generation of a human induced pluripotent stem cell line (UNAMi001-A) from a Mexican patient with sporadic Parkinson's disease. Stem cell research. vol 65. 2022-11-25. PMID:36427474. |
parkinson's disease (pd) is a neurodegenerative disease caused by progressive loss of dopaminergic neurons in the substantia nigra pars compacta, which results in motor alterations. |
2022-11-25 |
2023-08-14 |
human |
| Francesco Limone, Joseph R Klim, Daniel A Morde. Pluripotent stem cell strategies for rebuilding the human brain. Frontiers in aging neuroscience. vol 14. 2022-11-21. PMID:36408113. |
in this review, we cover advances in methods used to differentiate human pluripotent stem cells into several highly specialized types of neurons, including cholinergic, dopaminergic, and motor neurons, and the potential clinical applications of stem cell-derived neurons for common neurodegenerative diseases, including alzheimer's disease, parkinson's disease, huntington's disease, ataxia, and amyotrophic lateral sclerosis. |
2022-11-21 |
2023-08-14 |
human |
| Jaquelini B Canever, Ericks Sousa Soares, Núbia C P de Avelar, Helena I Cimarost. Targeting α-synuclein post-translational modifications in Parkinson's disease. Behavioural brain research. 2022-11-13. PMID:36372243. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the nigrostriatal pathway. |
2022-11-13 |
2023-08-14 |
Not clear |
| Shivam Kumar Pandey, Rakesh Kumar Sing. Recent developments in nucleic acid-based therapies for Parkinson's disease: Current status, clinical potential, and future strategies. Frontiers in pharmacology. vol 13. 2022-11-07. PMID:36339626. |
parkinson's disease is the second most common progressive neurodegenerative disease diagnosed mainly based on clinical symptoms caused by loss of nigrostriatal dopaminergic neurons. |
2022-11-07 |
2023-08-14 |
Not clear |
| Fei Gao, Han Zhang, Jia Yang, Menghua Cai, Qi Yang, Huaishan Wang, Yi Xu, Hui Chen, Yu Hu, Wei He, Jianmin Zhan. ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson's Disease-like Behavior. Cells. vol 11. issue 19. 2022-10-14. PMID:36230952. |
parkinson's disease (pd) is one of the most common neurodegenerative diseases and is pathologically characterized by α-synucleinopathy, which is harmful to dopaminergic neurons. |
2022-10-14 |
2023-08-14 |
mouse |